about
High incidence of somatic BAP1 alterations in sporadic malignant mesotheliomaDiagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysisRecent insights emerging from malignant mesothelioma genome sequencingMinimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesotheliomaLatest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapiesAn intrapleural administration of zoledronic acid for inoperable malignant mesothelioma patients: a phase I clinical study protocolPositive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesotheliomaMesothelioma: recent highlights.The Cappadocia mesothelioma epidemic: its influence in Turkey and abroad.In vitro experimental models of mesothelioma revisitedA clinical protocol to inhibit the HGF/c-Met pathway for malignant mesothelioma with an intrapleural injection of adenoviruses expressing the NK4 gene.Asbestos fibres detected by scanning electron microscopy in the gallbladder of patients with malignant pleural mesothelioma (MPM).Expression and activity of eIF6 trigger malignant pleural mesothelioma growth in vivo.Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma.Evaluating the effect of immune cells on the outcome of patients with mesothelioma.Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles.Improving the Accuracy of Mesothelioma Diagnosis in China.Malignant Mesothelioma: Time to Translate?Novel insights into mesothelioma biology and implications for therapy.Utility of BRCA1-associated protein 1 immunoperoxidase stain to differentiate benign versus malignant mesothelial proliferations in cytologic specimens.Mutational Profiling of Malignant Mesothelioma Revealed Potential Therapeutic Targets in EGFR and NRAS.New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma.Consensus report of the 8 and 9th Weinman Symposia on Gene x Environment Interaction in carcinogenesis: novel opportunities for precision medicine
P2860
Q24170431-FB2F9184-9F4D-43FA-99A2-B13461F587A3Q26748767-E5FBFC22-2D33-4DE2-9A6D-9C6D8967EF78Q28388301-C9FEAB59-403A-4B23-8ACA-D127672D8516Q28389071-E3B43875-B941-4EE9-9DE8-855331C80005Q28395597-AFBE1417-E390-45EC-BA61-3AC20AA7C2A9Q28603645-FC5D1312-9F4D-4143-824A-E96347AB23D4Q29248126-19F63340-FDAB-4640-9680-E8174DC9EFC4Q33871606-CE5A3E97-9BE7-4FDC-8DB8-24623CCA763CQ33871638-EF90433E-3F39-425C-B2D5-E9B7E1790F9CQ33890506-5C7C596D-AC13-4F1D-A5EB-2165ED13BA82Q35855798-00C190B8-76AA-4EEC-94A7-669525AE47FCQ36244124-5A2F93D9-A072-45FC-81B1-85D769A14033Q36545784-D4629D1F-F728-47C6-8DD2-D29CBFD0CEE8Q38429562-DA17C3F8-48BC-446A-83BF-81AB1B537B88Q38619743-681D147F-FD26-4E90-8395-61E5317E9C39Q38972707-00A76FD9-1F1E-4D82-BED9-8B6FE22A33F0Q39051001-3319EE42-E8A8-4BBA-A5F9-17FCFCDF9676Q39366003-FF1A9035-6DD0-4A87-B0E2-D5EC028E2F53Q39455555-3725FC1A-D75B-42C4-BD83-81709D2C829FQ48230081-36FBE236-DC12-4097-9844-6C8B2F5B50DCQ50137415-86590138-ADE8-44EA-8FC5-046E9DB044E9Q52581757-E7902A4E-C19D-4496-BCF2-0C1673FEE31CQ57461758-5C9505F6-D9B5-42C1-9E6A-8049CED92A97
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Evaluation of clonal origin of malignant mesothelioma
@ast
Evaluation of clonal origin of malignant mesothelioma
@en
Evaluation of clonal origin of malignant mesothelioma
@en-gb
Evaluation of clonal origin of malignant mesothelioma
@nl
type
label
Evaluation of clonal origin of malignant mesothelioma
@ast
Evaluation of clonal origin of malignant mesothelioma
@en
Evaluation of clonal origin of malignant mesothelioma
@en-gb
Evaluation of clonal origin of malignant mesothelioma
@nl
prefLabel
Evaluation of clonal origin of malignant mesothelioma
@ast
Evaluation of clonal origin of malignant mesothelioma
@en
Evaluation of clonal origin of malignant mesothelioma
@en-gb
Evaluation of clonal origin of malignant mesothelioma
@nl
P2093
P2860
P50
P3181
P1476
Evaluation of clonal origin of malignant mesothelioma
@en
P2093
Amy Powers
Barbara L Parsons
Haining Yang
Harvey I Pass
Joseph Friedberg
Mika Tanji
Oriana Strianese
Rosanna Mezzapelle
Shreya Kanodia
P2860
P2888
P3181
P356
10.1186/S12967-014-0301-3
P407
P50
P577
2014-01-01T00:00:00Z
P5875
P6179
1039551721